<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="365813">
  <stage>Registered</stage>
  <submitdate>26/02/2014</submitdate>
  <approvaldate>11/03/2014</approvaldate>
  <actrnumber>ACTRN12614000262606</actrnumber>
  <trial_identification>
    <studytitle>Ultrasound guided Transversus Abdominis Plane block: An evaluation of its efficacy in reducing post-op opioid requirements in Caesarean section</studytitle>
    <scientifictitle>Parturients undergoing elective Caesarean section, Transversus Abdominis Plane block compared to intravenous Morphine via Patient Controlled Analgesia PCA to achieve better Postoperative pain control.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>none</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Pain management after Caesarean section</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Childbirth and postnatal care</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Arm 1
patients will receive TAP block, 0.25% Bupivacaine 20 ml bilaterally along with PCA Morphine

Arm 2
patients will receive TAP block, 0.166% bupivacaine 30 ml bilaterally along with PCA Morphine

 TAP block is administered immediatly post caesarean section after skin suturing.
PCA Morphine is made available in immediate post operative period in recovery room.

PCA 1mg morphine per dose. lockout interval of 5 minutes. no background infusion and Maximum of 30 mg morphine per 4 hours.</interventions>
    <comparator>patients will receive only conventional analgesia via PCA morphine. It will be available immediately after surgery in the recovery room. 1 mg of morphine can be given per dose. no background infusion. lockout interval of 5 minutes and maximum 4 hours dose of 30 mg. </comparator>
    <control>Active</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>total morphine consumption in the first 24 hour</outcome>
      <timepoint>24 hours</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome> post op for pain score using the visual analogue scale</outcome>
      <timepoint>0, 6, 12 and 24 hours post operative</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Sedation scores using Richmond Agitation Sedation Scale (RASS]</outcome>
      <timepoint>0, 6, 12 and 24 hours post operative</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Post Operative Nausea and Vomiting PONV.
It is a yes/no outcome.</outcome>
      <timepoint>0, 6, 12 and 24 hours post operative</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Elective caesarean section.

ASA 1 and ASA 2 patients.

Patients receiving Spinal anaesthesia for surgery.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Emergency caesarean sections.
ASA 3 and ASA 4 patients.
Morbidly Obese patients.
Patients with local anaesthesia allergy</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>sealed opaque envelopes</concealment>
    <sequence>The closed envelopes contains the assigned plan of management. the envelops
method of randomisation is simple randomisation using a randomisation table from a statistic book   </sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/06/2013</anticipatedstartdate>
    <actualstartdate>22/06/2013</actualstartdate>
    <anticipatedenddate>1/06/2014</anticipatedenddate>
    <actualenddate />
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Bahrain</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Shahid Adeel</primarysponsorname>
    <primarysponsoraddress>King Hamad University Hospital, Anaesthesia department KHUH, Al Muharraq PO box 24343</primarysponsoraddress>
    <primarysponsorcountry>Bahrain</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>King Hamad University Hospital</fundingname>
      <fundingaddress>King Hamad University Hospital, Anaesthesia department, Al Muharraq PO box 24343
</fundingaddress>
      <fundingcountry>Bahrain</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Anaesthesia department KHUH</sponsorname>
      <sponsoraddress>King Hamad University Hospital, Anaesthesia department KHUH, Al Muharraq. PO box 24343</sponsoraddress>
      <sponsorcountry>Bahrain</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The transversus abdominis plane (TAP) block is a new regional anaesthesia technique that provides analgesia to the peritoneum, skin as well as the muscles of the anterior abdominal wall. It is easy to perform with a high margin of safety, especially under ultrasound guidance.

TAP blocks have been described as an effective component of multimodal postoperative analgesia for a wide variety of abdominal procedures including caesarean section.  Current reports demonstrated its safety and efficacy in reducing opioids consumption. Post-op analgesia in patient undergoing emergency caesarean section has conventionally been a multi-modal analgesia comprising of morphine PCA, regular paracetamol and NSAIDs. These have resulted in large consumption of morphine which is excreted via breast milk. These also result in higher sedation score and higher incidence of post operative nausea and vomiting</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Research and Ethics Committee of King Hamad University Hospital.</ethicname>
      <ethicaddress>Research and Ethics Committee of KHUH. Al Muharraq.
PO box 24343</ethicaddress>
      <ethicapprovaldate>18/06/2013</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Bahrain</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Shahid Adeel</name>
      <address>King Hamad University Hospital, Anaesthesia department. Al Muharraq. PO box 24343</address>
      <phone>+97333301673</phone>
      <fax />
      <email>shahid.adeel@khuh.org.bh</email>
      <country>Bahrain</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Shahid Adeel</name>
      <address>King Hamad University Hospital, Anaesthesia department. Al Muharraq PO box 24343</address>
      <phone>+97333301673</phone>
      <fax />
      <email>shahid.adeel@khuh.org.bh</email>
      <country>Bahrain</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>shahid Adeel</name>
      <address>King Hamad University Hospital, Anaesthesia department. Al Muharraq PO box 24343</address>
      <phone>+97333301673</phone>
      <fax />
      <email>shahid.adeel@khuh.org.bh</email>
      <country>Bahrain</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>